-
Iron and Cancer.
Torti, Suzy V; Manz, David H; Paul, Bibbin T; Blanchette-Farra, Nicole; Torti, Frank M Annual review of nutrition 2018 Aug;3897-125
-
Effects of ferroportin-mediated iron depletion in cells representative of different histological subtypes of prostate cancer.
Deng, Zhiyong; Manz, David H; Torti, Suzy; Torti, Frank M Antioxidants & redox signaling 2017 Oct;
-
Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth.
Deng, Zhiyong; Manz, David H; Torti, Suzy V; Torti, Frank M Oncotarget 2017 Jul;
-
DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.
Lemler, David J; Lynch, Miranda L; Tesfay, Lia; Deng, Zhiyong; Paul, Bibbin T; Wang, Xiaohong; Hegde, Poornima; Manz, David H; Torti, Suzy V; Torti, Frank M Breast cancer research : BCR 2017 Mar;19(1):25
-
Mitochondria and Iron: current questions.
Paul, Bibbin T; Manz, David H; Torti, Frank M; Torti, Suzy V Expert review of hematology 2017 Jan;10(1):65-79
-
Iron and cancer: recent insights.
Manz, David H; Blanchette, Nicole L; Paul, Bibbin T; Torti, Frank M; Torti, Suzy V Annals of the New York Academy of Sciences 2016 Feb;1368149-61
-
Modulation of hepcidin to treat iron deregulation: potential clinical applications.
Blanchette, Nicole L; Manz, David H; Torti, Frank M; Torti, Suzy V Expert review of hematology 2015 Dec;9169-86
-
Spatiotemporal changes to the subventricular zone stem cell pool through aging.
Shook, Brett A; Manz, David H; Peters, John J; Kang, Sangwook; Conover, Joanne C The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 May;32(20):6947-56
